For the patient with a clear weight goal — and the patient closer to it who wants to recompose. GLP-1 prescribed and titrated by a clinician, with the muscle-preservation, repletion, and side-effect layers most protocols leave out.
Sculpt is supervised work on body composition — the balance of fat and muscle, not a number on a scale read in isolation. That covers more than one kind of patient.
Some arrive with a substantial weight goal and want to reach it safely, holding on to muscle along the way. Some are closer to their goal and want to recompose — lose fat, build and preserve lean mass. Some have reached a good place and want to hold it. And some carry a metabolic or diabetic picture that shapes the whole protocol. Sculpt is built for all four.
What stays constant is the supervision. A clinician prescribes, titrates to your response, and watches the things that fast weight loss tends to cost — muscle, energy, the first weeks of side effects — so the loss is the kind you can keep.
A clear, larger weight goal. GLP-1 at the supervised pace your response sets, with muscle preservation and repletion built in from the start.
Closer to goal, focused on fat-to-muscle balance. A lighter metabolic touch paired with the muscle and recovery layers.
Holding a result. A bridge off the active phase and a plan for staying there, supervised rather than abandoned.
A diabetic or insulin-resistant picture that shapes the protocol. The clinician treats the metabolic reality, not just the weight.
GLP-1 medicines — semaglutide and tirzepatide among them — are the supervised core of Sculpt. Where more than one route is clinically sound, you see the trade-offs and decide.
At launch, the primary path is GLP-1 compounded by a state-licensed U.S. pharmacy. Branded options — the names you may already know — are offered as a fulfillment partner allows. You see both where both are available, with the cost and the trade-offs in plain view, and you choose.
Injection is the clinically preferred form, and the one with the deepest evidence behind it. An oral route exists for genuine needle aversion; where it's meaningfully less effective for your goal, the clinician tells you so before honoring the request. The choice stays yours — but it is an informed one.
Specific medicines and doses live in your prescription and your private dashboard, set by the clinician for you. They are not posted on a public page, because the right dose is the one titrated to your response — not a number copied from a website.
Each layer is optional, recommended by the clinician where your picture calls for it, and added to the protocol you build.
Rapid weight loss costs lean mass unless something protects it. This layer supports muscle through the catabolic window — the stretch where the body is most likely to burn the tissue you want to keep.
For the recomposition patient, a lighter adjunct layer aimed at fat metabolism rather than appetite — used where it fits the goal and the clinician agrees.
Eating less means taking in less of what the body still needs. The repletion layer keeps the nutritional substrate full so the protocol isn't quietly undermined by a deficiency.
The first weeks of GLP-1 are where most people struggle — nausea, slowed digestion. This layer anticipates that rather than waiting for it, so the early phase is survivable and you stay the course.
What happens after the goal is reached is where most protocols go quiet. This layer plans the off-ramp — how to taper, hold, and stay supervised rather than rebound.
Loss above roughly two pounds a week is where the gaunt face, the lost muscle, and the rebound tend to appear. We titrate to keep you under it.On pace, not just outcome
Leave an email and we will write to you — once — when the assessment opens.
Thank you. You are on the list. We will write when the practice opens.